Expedition Inspiration works with eminent medical professionals and researchers at hospitals and national research facilities to promote partnership grants and collaborative funding.

Collaborative Grants

Kathleen Grant, MD / California Pacific Medical Center
Stephanie Jeffery, MD / Stanford University
2002 Collaborative Research Award for "Comparison of Molecular Markers (Steroid Receptors) in Asian and Caucasian Breast Cancer Patients"
$16,750

Marc Lippman, MD / Lombardi Cancer Center
John Park, MD / Mt. Zion Cancer Center
2000 Collaborative Research Award for "Development of Anti-EGRI VIII Immunoliposomes for Tumor Specific Drug Delivery"
$20,000

George Vande Woude, Ph.D. / Van Andel Research Institute
Malcolm Mitchell, MD / Karmanos Cancer Institute
2000 Collaborative Research Award for "Development of Breast Cancer Vaccines: New Epitope Identification"
$20,000

Peggy Porter, MD / Fred Hutchinson Cancer Research Center
Karen Antman, MD / Columbia Presbyterian and/or Ruth Heimann, University of Chicago
1999 Collaborative Research Award for "Assessing the viability of CyclinE and p27 as prognostic markers through cooperative research"
$15,000

Research Grants

Peter A. Kaufman, MD / Dartmouth-Hitchcock, Norris Cotton Cancer Center
Research conducted through the Molecular Therapeutics Research Program.
$3,500 awarded in 2004 to support Dr. Kaufman
$5,000 granted in 2005 for continued support of Dr. Kaufman
$6,100 granted in 2006 for continued support of Dr. Kaufman
$7,125 granted in 2007 for continued support of Dr. Kaufman
$7,000 granted in 2008 for continued support of Dr. Kaufman
$10,000 granted in 2009 for continued support of Dr. Kaufman

Mountain States Tumor Institute 
2001: Clinical research related to monoclonal antibodies, a promising development in the treatment of breast cancer. 
$6,000 

Donald Kufe, MD / Dana Farber Cancer Institute 
2000: Trial using MUC1 gene in a phase I/II test to measure the safety of this vaccine in 18 women with metastatic breast cancer.
$7,500 
$10,000 granted in 2001 for the same study

Michael F. Press, MD, Ph.D. / USC / Kenneth Norris Comprehensive Cancer Center 
Investigating mechanisms for Tumorigenesis in HER-2/neu overexpressing breast cancers.
$50,000 ($25,000 matched by USC / Kenneth Norris Comprehensive Cancer Center in 1999)
$50,000 ($25,000 matched by USC/ Kenneth Norris Comprehensive Cancer Center in 2000) 
$26,000 granted in 2001 for continued support of Dr. Press
$33,000 granted in 2002 for continued support of Dr. Press
$82,000 granted in 2003 for continued support of Dr. Press
$23,800 granted in 2004 for continued support of Dr. Press
$28,000 granted in 2005 for continued support of Dr. Press
$23,100 granted for 2006 for continued support of Dr. Press
$27,000 granted in 2007 for continued support of Dr. Press
$5,500 granted in 2008 for continued support of Dr. Press
$5,500 granted in 2009 for continued support of Dr. Press

Todd Waldman, MD, Ph.D. / The Lombardi Cancer Center 
1999: Used in the study of somatic cell gene targeting and human tumor suppressor genes to further development of novel anticancer agents.
$10,000

Mountain States Tumor Institute 
Grant used to support data management of current breast cancer research protocols including bone marrow transplant procedures and the new Southwest Oncology adjuvant protocols.
$4,000 granted in 1999 
$2,750 granted in 2000 to support further study
$3,300 granted in 2001 to support further study

Helena Chang, MD / Revlon UCLA Breast Center 
Studies by of biological interventions in breast cancer prevention, diagnosis and treatment.
$50,000 ($25,000 matched by Jonsson Comprehensive Cancer Center in 1999)
$50,000 ($25,000 matched by Jonsson Comprehensive Cancer Center in 2000) 
$26,000 granted in 2001 for continued support of Dr. Chang
$33,000 granted in 2002 for continued support of Dr. Chang
$18,000 granted in 2003 for continued support of Dr. Chang
$23,800 granted in 2004 for continued support of Dr. Chang
$28,000 granted in 2005 for continued support of Dr. Chang
$23,100 granted in 2006 for continued support of Dr. Chang

Anna Maria Lopez, MD / Arizona Cancer Center 
1999: Grant to study the effect of Neuromuscular Integrative Action of (NIA) on the emotional and physical recovery of women with a history of breast cancer.
$20,000

Julie R. Gralow, MD / University Of Washington School Of Medicine 
Grant used to study the changes in breast tissue that occur in response to the addition of phytoestrogens to the diet of post-menopausal women to determine if plant estrogens can be a safe and effective alternative to estrogen replacement therapy.
$5,000 granted in 1999
$18,500 granted in 2000 for continued support of Dr. Gralow
$12,000 granted in 2001 for continued support of Dr. Gralow
$10,000 granted in 2002 for continued support of Dr. Gralow
$8,500 granted in 2003 for continued support of Dr. Gralow
$6,500 granted in 2004 for continued support of Dr. Gralow
$15,000 granted in 2005 for continued support of Dr. Gralow
$5,800 granted in 2006 for continued support of Dr. Gralow
$3,300 granted in 2007 for continued support of Dr. Gralow

USC / Kenneth Norris Comprehensive Cancer Center 
1999: Pilot study on the utility of preoperative chemotherapy for locally advanced breast cancer using the promising new agent Paclitaxel. 
$31,100

UCLA / Jonsson Comprehensive Cancer Center 
1999: Research on whether a change in the composition of fat in the diet, not just the quantity of fat intake, can slow or halt the growth of breast tumors. 
$21,100

Mountain States Medical Research Institute 
1998: Seed grant for the study of CD40 expression in breast cancer; involvement in cytotoxicity and immune enhancement that may lead to significantly improved cancer treatments. 
$15,000 

Fred Hutchinson Cancer Research Center 
1998: Grant for the development of community-based high dose chemotherapy programs that can be administered in smaller cancer centers. 
$17,000 

UCLA / Jonsson Comprehensive Cancer Center 
1998: Grant used for clinical trials utilizing new promising developmental therapies for recurring breast cancer to increase chance of long-term survival.
$30,000 (50% provided through UCLA matching funds)

USC / Kenneth Norris Comprehensive Cancer Center 
1998: Grant used for the detection of metastatic auxiliary lymph nodes with Positron Emission Tomography to reduce frequency of axillary node dissection and possibility of lymphedema side effect.
$30,000 (50% provided through USC matching funds)

Fred Hutchinson Cancer Research Center 
1998: Molecular determinants of acquired and intrinsic drug resistance in breast cancer to increase efficacy of adjuvant drug therapies.
$18,000

University Of Wisconsin Medical Center 
1998: Studies of a newly discovered natural substance (B-Lapachone derivatives) that kills metastatic breast cancer cells without toxicity to surrounding healthy cells. 
$10,000

Duke Comprehensive Cancer Center 
1998: Immunotherapy of breast cancer using autologous Dendritic cells pulsed with tumor Antigen. 
$20,000

Jingwen Liu, Ph.D. / Mountain States Medical Research Institute 
1997: Oncosatin M (OM) research, a cytokine produced by white blood cells in the immune system which inhibits growth of breast cancer cells by blocking action of certain factors driving the wild growth of cancer cells. 
$10,000

University Of Pennsylvania Cancer Center 
1997: Phase I trial with TALL-104 cells in-patients with metastatic breast cancer.
$10,000

UCLA / Jonsson Comprehensive Cancer Center 
1997: Studies as to whether a moderate intensity exercise program can decrease estrogen levels in premenopausal women at high risk for breast cancer.
$10,000 

The Wistar Institute 
1997: Research to isolate human genes associated with the process of metastatic breast cancer as well as continued study into the function of the BRCA 1 gene. 
$30,000

Fred Hutchinson Cancer Research Center 
1997: Scrutinizing societal shifts involving diet, exercise and environmental changes that may account for increase in breast cancer incidence. 
$25,000